HEADER HYDROLASE 08-FEB-06 2CEK TITLE CONFORMATIONAL FLEXIBILITY IN THE PERIPHERAL SITE OF TORPEDO TITLE 2 CALIFORNICA ACETYLCHOLINESTERASE REVEALED BY THE COMPLEX STRUCTURE TITLE 3 WITH A BIFUNCTIONAL INHIBITOR CAVEAT 2CEK NAG A 596 HAS WRONG CHIRALITY AT ATOM C1 COMPND MOL_ID: 1; COMPND 2 MOLECULE: ACETYLCHOLINESTERASE; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: ACHE; COMPND 5 EC: 3.1.1.7 SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: TORPEDO CALIFORNICA; SOURCE 3 ORGANISM_COMMON: PACIFIC ELECTRIC RAY; SOURCE 4 ORGANISM_TAXID: 7787; SOURCE 5 VARIANT: G2 FORM; SOURCE 6 ORGAN: ELECTRIC ORGAN; SOURCE 7 TISSUE: ELECTROPLAQUE KEYWDS ALPHA/BETA HYDROLASE, SERINE ESTERASE, NEUROTRANSMITTER CLEAVAGE, KEYWDS 2 SYNAPSE MEMBRANE, GLYCOPROTEIN, GPI-ANCHOR, ALZHEIMER DISEASE, KEYWDS 3 CONFORMATIONAL FLEXIBILITY, ALTERNATIVE SPLICING, LIPOPROTEIN, KEYWDS 4 NEUROTRANSMITTER DEGRADATION, HYDROLASE, SYNAPSE EXPDTA X-RAY DIFFRACTION AUTHOR B.SANSON,J.P.COLLETIER,F.NACHON,E.GABELLIERI,C.FATTORUSSO,G.CAMPIANI, AUTHOR 2 M.WEIK REVDAT 7 13-DEC-23 2CEK 1 REMARK REVDAT 6 12-MAY-21 2CEK 1 REMARK HETSYN REVDAT 5 29-JUL-20 2CEK 1 COMPND REMARK HETNAM LINK REVDAT 5 2 1 SITE ATOM REVDAT 4 08-MAY-19 2CEK 1 REMARK LINK REVDAT 3 25-JUL-18 2CEK 1 CAVEAT COMPND JRNL HET REVDAT 3 2 1 HETNAM FORMUL LINK ATOM REVDAT 2 24-FEB-09 2CEK 1 VERSN REVDAT 1 10-APR-06 2CEK 0 JRNL AUTH J.P.COLLETIER,B.SANSON,F.NACHON,E.GABELLIERI,C.FATTORUSSO, JRNL AUTH 2 G.CAMPIANI,M.WEIK JRNL TITL CONFORMATIONAL FLEXIBILITY IN THE PERIPHERAL SITE OF TORPEDO JRNL TITL 2 CALIFORNICA ACETYLCHOLINESTERASE REVEALED BY THE COMPLEX JRNL TITL 3 STRUCTURE WITH A BIFUNCTIONAL INHIBITOR. JRNL REF J. AM. CHEM. SOC. V. 128 4526 2006 JRNL REFN ISSN 0002-7863 JRNL PMID 16594661 JRNL DOI 10.1021/JA058683B REMARK 2 REMARK 2 RESOLUTION. 2.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 3339666.630 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 50867 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.175 REMARK 3 FREE R VALUE : 0.206 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 2537 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.004 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.20 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.34 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 100.0 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 7982 REMARK 3 BIN R VALUE (WORKING SET) : 0.2720 REMARK 3 BIN FREE R VALUE : 0.3000 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.80 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 402 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.015 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4245 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 158 REMARK 3 SOLVENT ATOMS : 660 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 27.10 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 43.00 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 8.26000 REMARK 3 B22 (A**2) : 8.26000 REMARK 3 B33 (A**2) : -16.52000 REMARK 3 B12 (A**2) : 4.93000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.22 REMARK 3 ESD FROM SIGMAA (A) : 0.30 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.27 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.34 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.006 REMARK 3 BOND ANGLES (DEGREES) : 1.300 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 22.40 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.860 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.190 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 1.870 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 2.070 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 3.030 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.36 REMARK 3 BSOL : 75.59 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : CARBOHYDRATE.PARAM REMARK 3 PARAMETER FILE 3 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 4 : LIG.PARAM REMARK 3 PARAMETER FILE 5 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : CARBOHYDRATE.TOP REMARK 3 TOPOLOGY FILE 3 : WATER.TOP REMARK 3 TOPOLOGY FILE 4 : LIG.TOP REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: BULK SOLVENT MODEL USED REMARK 4 REMARK 4 2CEK COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 08-FEB-06. REMARK 100 THE DEPOSITION ID IS D_1290027543. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 10-FEB-05 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID14-2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.932 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 50867 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.200 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 4.920 REMARK 200 R MERGE (I) : 0.06000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 16.1800 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.33 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.9 REMARK 200 DATA REDUNDANCY IN SHELL : 4.98 REMARK 200 R MERGE FOR SHELL (I) : 0.39000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.360 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: PDB ENTRY 1EA5 REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 68.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.80 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 32% PEG200, 150MM MES, PH6.0, 4DEG. C. REMARK 280 12 HOURS OF SOAKING WITH A PUTATIVE ANTI-ALZHEIMER DRUG., REMARK 280 TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 31 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+2/3 REMARK 290 6555 -X,-X+Y,-Z+1/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 45.70667 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 91.41333 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 91.41333 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 45.70667 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 2 -0.500000 0.866025 0.000000 0.00000 REMARK 350 BIOMT2 2 0.866025 0.500000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 137.12000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A2276 LIES ON A SPECIAL POSITION. REMARK 400 REMARK 400 COMPOUND REMARK 400 RAPIDLY HYDROLYZES CHOLINE RELEASED INTO THE SYNAPSE REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ASP A 1 REMARK 465 ASP A 2 REMARK 465 HIS A 3 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 25 -157.70 -136.41 REMARK 500 PHE A 45 -9.03 81.29 REMARK 500 ALA A 60 50.05 -109.24 REMARK 500 SER A 108 77.42 -160.64 REMARK 500 ASN A 167 7.31 57.82 REMARK 500 SER A 200 -125.36 59.27 REMARK 500 GLU A 299 -68.32 -120.38 REMARK 500 ASP A 380 51.88 -158.91 REMARK 500 ASP A 380 51.88 -153.66 REMARK 500 VAL A 400 -68.51 -127.16 REMARK 500 ASN A 457 77.20 35.83 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: PLANAR GROUPS REMARK 500 REMARK 500 PLANAR GROUPS IN THE FOLLOWING RESIDUES HAVE A TOTAL REMARK 500 RMS DISTANCE OF ALL ATOMS FROM THE BEST-FIT PLANE REMARK 500 BY MORE THAN AN EXPECTED VALUE OF 6*RMSD, WITH AN REMARK 500 RMSD 0.02 ANGSTROMS, OR AT LEAST ONE ATOM HAS REMARK 500 AN RMSD GREATER THAN THIS VALUE REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI RMS TYPE REMARK 500 TYR A 442 0.07 SIDE CHAIN REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A2022 DISTANCE = 6.02 ANGSTROMS REMARK 525 HOH A2037 DISTANCE = 5.86 ANGSTROMS REMARK 525 HOH A2090 DISTANCE = 6.30 ANGSTROMS REMARK 525 HOH A2185 DISTANCE = 6.08 ANGSTROMS REMARK 525 HOH A2189 DISTANCE = 6.08 ANGSTROMS REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1ACJ RELATED DB: PDB REMARK 900 ACETYLCHOLINESTERASE COMPLEXED WITH TACRINE REMARK 900 RELATED ID: 1ACL RELATED DB: PDB REMARK 900 ACETYLCHOLINESTERASE COMPLEXED WITH DECAMETHONIUM REMARK 900 RELATED ID: 1AMN RELATED DB: PDB REMARK 900 TRANSITION STATE ANALOG: ACETYLCHOLINESTERASE COMPLEXED WITH M-(N,N, REMARK 900 N-TRIMETHYLAMMONIO) TRIFLUOROACETOPHENONE REMARK 900 RELATED ID: 1AX9 RELATED DB: PDB REMARK 900 ACETYLCHOLINESTERASE COMPLEXED WITH EDROPHONIUM, LAUE DATA REMARK 900 RELATED ID: 1CFJ RELATED DB: PDB REMARK 900 METHYLPHOSPHONYLATED ACETYLCHOLINESTERASE (AGED) OBTAINED BY REMARK 900 REACTION WITH O- ISOPROPYLMETHYLPHOSPHONOFLUORIDATE (GB, SARIN) REMARK 900 RELATED ID: 1DX6 RELATED DB: PDB REMARK 900 STRUCTURE OF ACETYLCHOLINESTERASE COMPLEXED WITH (-)-GALANTHAMINE REMARK 900 AT 2.3A RESOLUTION REMARK 900 RELATED ID: 1E3Q RELATED DB: PDB REMARK 900 TORPEDO CALIFORNICA ACETYLCHOLINESTERASE COMPLEXED WITH BW284C51 REMARK 900 RELATED ID: 1E66 RELATED DB: PDB REMARK 900 STRUCTURE OF ACETYLCHOLINESTERASE COMPLEXED WITH (-)-HUPRINE X AT REMARK 900 2.1A RESOLUTION REMARK 900 RELATED ID: 1EA5 RELATED DB: PDB REMARK 900 NATIVE ACETYLCHOLINESTERASE (E.C. 3.1.1.7 ) FROM TORPEDO REMARK 900 CALIFORNICA AT 1.8A RESOLUTION REMARK 900 RELATED ID: 1EEA RELATED DB: PDB REMARK 900 ACETYLCHOLINESTERASE REMARK 900 RELATED ID: 1EVE RELATED DB: PDB REMARK 900 THREE DIMENSIONAL STRUCTURE OF THE ANTI- ALZHEIMER DRUG, E2020 REMARK 900 (ARICEPT), COMPLEXED WITH ITS TARGET ACETYLCHOLINESTERASE REMARK 900 RELATED ID: 1FSS RELATED DB: PDB REMARK 900 ACETYLCHOLINESTERASE COMPLEXED WITH FASCICULIN- II REMARK 900 RELATED ID: 1GPK RELATED DB: PDB REMARK 900 STRUCTURE OF ACETYLCHOLINESTERASE COMPLEXE WITH (+)-HUPERZINE A AT REMARK 900 2.1A RESOLUTION REMARK 900 RELATED ID: 1GPN RELATED DB: PDB REMARK 900 STRUCTURE OF ACETYLCHOLINESTERASE COMPLEXED WITH HUPERZINE B AT REMARK 900 2.35A RESOLUTION REMARK 900 RELATED ID: 1GQR RELATED DB: PDB REMARK 900 ACETYLCHOLINESTERASE (E.C. 3.1.1.7) COMPLEXED WITH RIVASTIGMINE REMARK 900 RELATED ID: 1GQS RELATED DB: PDB REMARK 900 ACETYLCHOLINESTERASE (E.C. 3.1.1.7) COMPLEXED WITH NAP REMARK 900 RELATED ID: 1H22 RELATED DB: PDB REMARK 900 STRUCTURE OF ACETYLCHOLINESTERASE (E.C. 3.1 .1.7) COMPLEXED WITH (S, REMARK 900 S)-(-)-BIS(10)- HUPERZINE A-LIKE INHIBITOR AT 2.15A RESOLUTION REMARK 900 RELATED ID: 1H23 RELATED DB: PDB REMARK 900 STRUCTURE OF ACETYLCHOLINESTERASE (E.C. 3.1 .1.7) COMPLEXED WITH (S, REMARK 900 S)-(-)-BIS(12)- HUPERZINE A-LIKE INHIBITOR AT 2.15A RESOLUTION REMARK 900 RELATED ID: 1HBJ RELATED DB: PDB REMARK 900 X-RAY CRYSTAL STRUCTURE OF COMPLEX BETWEEN TORPEDO CALIFORNICA ACHE REMARK 900 AND A REVERSIBLE INHIBITOR, 4-AMINO-5-FLUORO-2-METHYL-3-( 3- REMARK 900 TRIFLUOROACETYLBENZYLTHIOMETHYL)QUINOLINE REMARK 900 RELATED ID: 1JGA RELATED DB: PDB REMARK 900 THEORETICAL MODEL OF THE DIISOPROPYLPHOSPHORYL- REMARK 900 ACETYLCHOLINESTERASE COMPLEXED WITH 1,7- HEPTYLENE-BIS-N,N'-SYN-2- REMARK 900 PYRIDINIUMALDOXIME REMARK 900 RELATED ID: 1JGB RELATED DB: PDB REMARK 900 THEORETICAL MODEL OF THE DIISOPROPYLPHOSPHORYL- REMARK 900 ACETYLCHOLINESTERASE COMPLEXED WITH 1,3- PROPYLENE-BIS-N,N'-SYN-4- REMARK 900 PYRIDINIUMALDOXIME REMARK 900 RELATED ID: 1JJB RELATED DB: PDB REMARK 900 A NEUTRAL MOLECULE IN CATION-BINDING SITE: SPECIFIC BINDINGOF PEG- REMARK 900 SH TO ACETYLCHOLINESTERASE FROM TORPEDO CALIFORNICA REMARK 900 RELATED ID: 1OCE RELATED DB: PDB REMARK 900 ACETYLCHOLINESTERASE COMPLEXED WITH MF268 REMARK 900 RELATED ID: 1ODC RELATED DB: PDB REMARK 900 STRUCTURE OF ACETYLCHOLINESTERASE (E.C. 3.1 .1.7) COMPLEXED WITH N- REMARK 900 4'-QUINOLYL-N'-9 "-(1",2",3",4"-TETRAHYDROACRIDINYL)-1,8- REMARK 900 DIAMINOOCTANE AT 2.2A RESOLUTION REMARK 900 RELATED ID: 1QID RELATED DB: PDB REMARK 900 SPECIFIC CHEMICAL AND STRUCTURAL DAMAGE AT NINE TIME POINTS (POINT REMARK 900 A) CAUSED BY INTENSE SYNCHROTRON RADIATION TO TORPEDO CALIFORNICA REMARK 900 ACETYLCHOLINESTERASE REMARK 900 RELATED ID: 1QIE RELATED DB: PDB REMARK 900 SPECIFIC CHEMICAL AND STRUCTURAL DAMAGE AT NINE TIME POINTS (POINT REMARK 900 B) CAUSED BY INTENSE SYNCHROTRON RADIATION TO TORPEDO CALIFORNICA REMARK 900 ACETYLCHOLINESTERASE REMARK 900 RELATED ID: 1QIF RELATED DB: PDB REMARK 900 SPECIFIC CHEMICAL AND STRUCTURAL DAMAGE AT NINE TIME POINTS (POINT REMARK 900 C) CAUSED BY INTENSE SYNCHROTRON RADIATION TO TORPEDO CALIFORNICA REMARK 900 ACETYLCHOLINESTERASE REMARK 900 RELATED ID: 1QIG RELATED DB: PDB REMARK 900 SPECIFIC CHEMICAL AND STRUCTURAL DAMAGE AT NINE TIME POINTS (POINT REMARK 900 D) CAUSED BY INTENSE SYNCHROTRON RADIATION TO TORPEDO CALIFORNICA REMARK 900 ACETYLCHOLINESTERASE REMARK 900 RELATED ID: 1QIH RELATED DB: PDB REMARK 900 SPECIFIC CHEMICAL AND STRUCTURAL DAMAGE AT NINE TIME POINTS (POINT REMARK 900 E) CAUSED BY INTENSE SYNCHROTRON RADIATION TO TORPEDO CALIFORNICA REMARK 900 ACETYLCHOLINESTERASE REMARK 900 RELATED ID: 1QII RELATED DB: PDB REMARK 900 SPECIFIC CHEMICAL AND STRUCTURAL DAMAGE AT NINE TIME POINTS (POINT REMARK 900 F) CAUSED BY INTENSE SYNCHROTRON RADIATION TO TORPEDO CALIFORNICA REMARK 900 ACETYLCHOLINESTERASE REMARK 900 RELATED ID: 1QIJ RELATED DB: PDB REMARK 900 SPECIFIC CHEMICAL AND STRUCTURAL DAMAGE AT NINE TIME POINTS (POINT REMARK 900 G) CAUSED BY INTENSE SYNCHROTRON RADIATION TO TORPEDO CALIFORNICA REMARK 900 ACETYLCHOLINESTERASE REMARK 900 RELATED ID: 1QIK RELATED DB: PDB REMARK 900 SPECIFIC CHEMICAL AND STRUCTURAL DAMAGE AT NINE TIME POINTS (POINT REMARK 900 H) CAUSED BY INTENSE SYNCHROTRON RADIATION TO TORPEDO CALIFORNICA REMARK 900 ACETYLCHOLINESTERASE REMARK 900 RELATED ID: 1QIM RELATED DB: PDB REMARK 900 SPECIFIC CHEMICAL AND STRUCTURAL DAMAGE AT NINE TIME POINTS (POINT REMARK 900 I) CAUSED BY INTENSE SYNCHROTRON RADIATION TO TORPEDO CALIFORNICA REMARK 900 ACETYLCHOLINESTERASE REMARK 900 RELATED ID: 1QTI RELATED DB: PDB REMARK 900 ACETYLCHOLINESTERASE REMARK 900 RELATED ID: 1SOM RELATED DB: PDB REMARK 900 TORPEDO CALIFORNICA ACETYLCHOLINESTERASE INHIBITED BY NERVE AGENT REMARK 900 GD (SOMAN). REMARK 900 RELATED ID: 1U65 RELATED DB: PDB REMARK 900 ACHE W. CPT-11 REMARK 900 RELATED ID: 1UT6 RELATED DB: PDB REMARK 900 STRUCTURE OF ACETYLCHOLINESTERASE (E.C. 3.1 .1.7) COMPLEXED WITH N- REMARK 900 9-(1',2',3',4 '-TETRAHYDROACRIDINYL)-1,8- DIAMINOOCTANE AT 2.4 REMARK 900 ANGSTROMS RESOLUTION. REMARK 900 RELATED ID: 1VOT RELATED DB: PDB REMARK 900 ACETYLCHOLINESTERASE COMPLEXED WITH HUPERZINE A REMARK 900 RELATED ID: 1VXO RELATED DB: PDB REMARK 900 METHYLPHOSPHONYLATED ACETYLCHOLINESTERASE (AGED) OBTAINED BY REMARK 900 REACTION WITH O-ETHYL-S-[2-[ BIS(1-METHYLETHYL) AMINO]ETHYL] REMARK 900 METHYLPHOSPHONOTHIOATE (VX) REMARK 900 RELATED ID: 1VXR RELATED DB: PDB REMARK 900 O-ETHYLMETHYLPHOSPHONYLATED ACETYLCHOLINESTERASE OBTAINED BY REMARK 900 REACTION WITH O-ETHYL-S-[2-[ BIS(1-METHYLETHYL) AMINO]ETHYL] REMARK 900 METHYLPHOSPHONOTHIOATE (VX) REMARK 900 RELATED ID: 1W4L RELATED DB: PDB REMARK 900 COMPLEX OF TCACHE WITH BIS-ACTING GALANTHAMINE DERIVATIVE REMARK 900 RELATED ID: 1W6R RELATED DB: PDB REMARK 900 COMPLEX OF TCACHE WITH GALANTHAMINE DERIVATIVE REMARK 900 RELATED ID: 1W75 RELATED DB: PDB REMARK 900 NATIVE ORTHORHOMBIC FORM OF TORPEDO CALIFORNICA REMARK 900 ACETYLCHOLINESTERASE (ACHE) REMARK 900 RELATED ID: 1W76 RELATED DB: PDB REMARK 900 ORTHORHOMBIC FORM OF TORPEDO CALIFORNICA ACETYLCHOLINESTERASE (ACHE) REMARK 900 COMPLEXED WITH BIS- ACTING GALANTHAMINE DERIVATIVE REMARK 900 RELATED ID: 1ZGB RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF TORPEDO CALIFORNICAACETYLCHOLINESTERASE IN REMARK 900 COMPLEX WITH AN (R)-TACRINE(10)-HUPYRIDONE INHIBITOR. REMARK 900 RELATED ID: 1ZGC RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF TORPEDO CALIFORNICAACETYLCHOLINESTERASE IN REMARK 900 COMPLEX WITH AN (RS)-TACRINE(10)-HUPYRIDONE INHIBITOR. REMARK 900 RELATED ID: 2ACE RELATED DB: PDB REMARK 900 NATIVE ACETYLCHOLINESTERASE FROM TORPEDO CALIFORNICA REMARK 900 RELATED ID: 2ACK RELATED DB: PDB REMARK 900 ACETYLCHOLINESTERASE COMPLEXED WITH EDROPHONIUM, MONOCHROMATIC DATA REMARK 900 RELATED ID: 2C4H RELATED DB: PDB REMARK 900 TORPEDO CALIFORNICA ACETYLCHOLINESTERASE IN COMPLEX WITH 500MM REMARK 900 ACETYLTHIOCHOLINE REMARK 900 RELATED ID: 2C58 RELATED DB: PDB REMARK 900 TORPEDO CALIFORNICA ACETYLCHOLINESTERASE IN COMPLEX WITH 20MM REMARK 900 ACETYLTHIOCHOLINE REMARK 900 RELATED ID: 2C5F RELATED DB: PDB REMARK 900 TORPEDO CALIFORNICA ACETYLCHOLINESTERASE IN COMPLEX WITH A NON REMARK 900 HYDROLYSABLE SUBSTRATE ANALOGUE, 4-OXO-N,N,N-TRIMETHYLAMMONIUM REMARK 900 RELATED ID: 2C5G RELATED DB: PDB REMARK 900 TORPEDO CALIFORNICA ACETYLCHOLINESTERASE IN COMPLEX WITH 20MM REMARK 900 THIOCHOLINE REMARK 900 RELATED ID: 2DFP RELATED DB: PDB REMARK 900 X-RAY STRUCTURE OF AGED DI-ISOPROPYL- PHOSPHORO-FLUORIDATE (DFP) REMARK 900 BOUND TO ACETYLCHOLINESTERASE REMARK 900 RELATED ID: 3ACE RELATED DB: PDB REMARK 900 THEORETICAL MODEL OF (R)-E2020 BOUND ACETYLCHOLINESTERASE COMPLEX, REMARK 900 3 STRUCTURES REMARK 900 RELATED ID: 4ACE RELATED DB: PDB REMARK 900 THEORETICAL MODEL OF (S)-E2020 BOUND ACETYLCHOLINESTERASE COMPLEX, REMARK 900 3 STRUCTURES DBREF 2CEK A 1 535 UNP P04058 ACES_TORCA 22 556 SEQRES 1 A 535 ASP ASP HIS SER GLU LEU LEU VAL ASN THR LYS SER GLY SEQRES 2 A 535 LYS VAL MET GLY THR ARG VAL PRO VAL LEU SER SER HIS SEQRES 3 A 535 ILE SER ALA PHE LEU GLY ILE PRO PHE ALA GLU PRO PRO SEQRES 4 A 535 VAL GLY ASN MET ARG PHE ARG ARG PRO GLU PRO LYS LYS SEQRES 5 A 535 PRO TRP SER GLY VAL TRP ASN ALA SER THR TYR PRO ASN SEQRES 6 A 535 ASN CYS GLN GLN TYR VAL ASP GLU GLN PHE PRO GLY PHE SEQRES 7 A 535 SER GLY SER GLU MET TRP ASN PRO ASN ARG GLU MET SER SEQRES 8 A 535 GLU ASP CYS LEU TYR LEU ASN ILE TRP VAL PRO SER PRO SEQRES 9 A 535 ARG PRO LYS SER THR THR VAL MET VAL TRP ILE TYR GLY SEQRES 10 A 535 GLY GLY PHE TYR SER GLY SER SER THR LEU ASP VAL TYR SEQRES 11 A 535 ASN GLY LYS TYR LEU ALA TYR THR GLU GLU VAL VAL LEU SEQRES 12 A 535 VAL SER LEU SER TYR ARG VAL GLY ALA PHE GLY PHE LEU SEQRES 13 A 535 ALA LEU HIS GLY SER GLN GLU ALA PRO GLY ASN VAL GLY SEQRES 14 A 535 LEU LEU ASP GLN ARG MET ALA LEU GLN TRP VAL HIS ASP SEQRES 15 A 535 ASN ILE GLN PHE PHE GLY GLY ASP PRO LYS THR VAL THR SEQRES 16 A 535 ILE PHE GLY GLU SER ALA GLY GLY ALA SER VAL GLY MET SEQRES 17 A 535 HIS ILE LEU SER PRO GLY SER ARG ASP LEU PHE ARG ARG SEQRES 18 A 535 ALA ILE LEU GLN SER GLY SER PRO ASN CYS PRO TRP ALA SEQRES 19 A 535 SER VAL SER VAL ALA GLU GLY ARG ARG ARG ALA VAL GLU SEQRES 20 A 535 LEU GLY ARG ASN LEU ASN CYS ASN LEU ASN SER ASP GLU SEQRES 21 A 535 GLU LEU ILE HIS CYS LEU ARG GLU LYS LYS PRO GLN GLU SEQRES 22 A 535 LEU ILE ASP VAL GLU TRP ASN VAL LEU PRO PHE ASP SER SEQRES 23 A 535 ILE PHE ARG PHE SER PHE VAL PRO VAL ILE ASP GLY GLU SEQRES 24 A 535 PHE PHE PRO THR SER LEU GLU SER MET LEU ASN SER GLY SEQRES 25 A 535 ASN PHE LYS LYS THR GLN ILE LEU LEU GLY VAL ASN LYS SEQRES 26 A 535 ASP GLU GLY SER PHE PHE LEU LEU TYR GLY ALA PRO GLY SEQRES 27 A 535 PHE SER LYS ASP SER GLU SER LYS ILE SER ARG GLU ASP SEQRES 28 A 535 PHE MET SER GLY VAL LYS LEU SER VAL PRO HIS ALA ASN SEQRES 29 A 535 ASP LEU GLY LEU ASP ALA VAL THR LEU GLN TYR THR ASP SEQRES 30 A 535 TRP MET ASP ASP ASN ASN GLY ILE LYS ASN ARG ASP GLY SEQRES 31 A 535 LEU ASP ASP ILE VAL GLY ASP HIS ASN VAL ILE CYS PRO SEQRES 32 A 535 LEU MET HIS PHE VAL ASN LYS TYR THR LYS PHE GLY ASN SEQRES 33 A 535 GLY THR TYR LEU TYR PHE PHE ASN HIS ARG ALA SER ASN SEQRES 34 A 535 LEU VAL TRP PRO GLU TRP MET GLY VAL ILE HIS GLY TYR SEQRES 35 A 535 GLU ILE GLU PHE VAL PHE GLY LEU PRO LEU VAL LYS GLU SEQRES 36 A 535 LEU ASN TYR THR ALA GLU GLU GLU ALA LEU SER ARG ARG SEQRES 37 A 535 ILE MET HIS TYR TRP ALA THR PHE ALA LYS THR GLY ASN SEQRES 38 A 535 PRO ASN GLU PRO HIS SER GLN GLU SER LYS TRP PRO LEU SEQRES 39 A 535 PHE THR THR LYS GLU GLN LYS PHE ILE ASP LEU ASN THR SEQRES 40 A 535 GLU PRO MET LYS VAL HIS GLN ARG LEU ARG VAL GLN MET SEQRES 41 A 535 CYS VAL PHE TRP ASN GLN PHE LEU PRO LYS LEU LEU ASN SEQRES 42 A 535 ALA THR MODRES 2CEK ASN A 59 ASN GLYCOSYLATION SITE MODRES 2CEK ASN A 416 ASN GLYCOSYLATION SITE MODRES 2CEK ASN A 457 ASN GLYCOSYLATION SITE HET NAG B 1 14 HET NAG B 2 14 HET NAG A 596 14 HET NAG A 599 14 HET N8T A 600 38 HET MES A 601 12 HET MES A 602 12 HET PGE A 700 10 HET PGE A 701 10 HET PGE A 702 10 HET PGE A 703 10 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM N8T N-[8-(1,2,3,4-TETRAHYDROACRIDIN-9-YLTHIO)OCTYL]-1,2,3, HETNAM 2 N8T 4-TETRAHYDROACRIDIN-9-AMINE HETNAM MES 2-(N-MORPHOLINO)-ETHANESULFONIC ACID HETNAM PGE TRIETHYLENE GLYCOL HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE HETSYN N8T N-(1,2,3,4-TETRAHYDROACRIDIN-9-YL)-8-[(1,2,3,4- HETSYN 2 N8T TETRAHYDROACRIDIN-9-YL)THIO]-O CTAN-1-AMINE FORMUL 2 NAG 4(C8 H15 N O6) FORMUL 5 N8T C34 H41 N3 S FORMUL 6 MES 2(C6 H13 N O4 S) FORMUL 8 PGE 4(C6 H14 O4) FORMUL 12 HOH *660(H2 O) HELIX 1 1 VAL A 40 ARG A 44 5 5 HELIX 2 2 PHE A 78 MET A 83 1 6 HELIX 3 3 LEU A 127 ASN A 131 5 5 HELIX 4 4 GLY A 132 GLU A 140 1 9 HELIX 5 5 VAL A 150 LEU A 156 1 7 HELIX 6 6 ASN A 167 ILE A 184 1 18 HELIX 7 7 GLN A 185 PHE A 187 5 3 HELIX 8 8 SER A 200 SER A 212 1 13 HELIX 9 9 SER A 215 PHE A 219 5 5 HELIX 10 10 VAL A 238 LEU A 252 1 15 HELIX 11 11 SER A 258 LYS A 269 1 12 HELIX 12 12 LYS A 270 GLU A 278 1 9 HELIX 13 13 TRP A 279 LEU A 282 5 4 HELIX 14 14 SER A 304 GLY A 312 1 9 HELIX 15 15 GLY A 328 ALA A 336 1 9 HELIX 16 16 SER A 348 VAL A 360 1 13 HELIX 17 17 ASN A 364 TYR A 375 1 12 HELIX 18 18 ASN A 383 VAL A 400 1 18 HELIX 19 19 VAL A 400 LYS A 413 1 14 HELIX 20 20 PRO A 433 GLY A 437 5 5 HELIX 21 21 GLU A 443 PHE A 448 1 6 HELIX 22 22 GLY A 449 VAL A 453 5 5 HELIX 23 23 VAL A 453 ASN A 457 5 5 HELIX 24 24 THR A 459 GLY A 480 1 22 HELIX 25 25 ARG A 517 GLN A 526 1 10 HELIX 26 26 GLN A 526 THR A 535 1 10 SHEET 1 AA 3 LEU A 7 THR A 10 0 SHEET 2 AA 3 GLY A 13 MET A 16 -1 O GLY A 13 N THR A 10 SHEET 3 AA 3 VAL A 57 ASN A 59 1 O TRP A 58 N MET A 16 SHEET 1 AB11 THR A 18 VAL A 22 0 SHEET 2 AB11 SER A 25 PRO A 34 -1 O SER A 25 N VAL A 22 SHEET 3 AB11 TYR A 96 VAL A 101 -1 O LEU A 97 N ILE A 33 SHEET 4 AB11 VAL A 142 SER A 145 -1 O LEU A 143 N TRP A 100 SHEET 5 AB11 THR A 109 ILE A 115 1 O THR A 110 N VAL A 142 SHEET 6 AB11 GLY A 189 GLU A 199 1 N ASP A 190 O THR A 109 SHEET 7 AB11 ARG A 221 GLN A 225 1 O ARG A 221 N ILE A 196 SHEET 8 AB11 ILE A 319 ASN A 324 1 O LEU A 320 N LEU A 224 SHEET 9 AB11 THR A 418 PHE A 423 1 O TYR A 419 N LEU A 321 SHEET 10 AB11 LYS A 501 LEU A 505 1 O ILE A 503 N PHE A 422 SHEET 11 AB11 VAL A 512 GLN A 514 -1 O HIS A 513 N PHE A 502 SHEET 1 AC 2 VAL A 236 SER A 237 0 SHEET 2 AC 2 VAL A 295 ILE A 296 1 N ILE A 296 O VAL A 236 SSBOND 1 CYS A 67 CYS A 94 1555 1555 2.04 SSBOND 2 CYS A 254 CYS A 265 1555 1555 2.03 SSBOND 3 CYS A 402 CYS A 521 1555 1555 2.04 LINK ND2 ASN A 59 C1 NAG A 599 1555 1555 1.46 LINK ND2 ASN A 416 C1 NAG B 1 1555 1555 1.45 LINK ND2 ASN A 457 C1 NAG A 596 1555 1555 1.45 LINK O4 NAG B 1 C1 NAG B 2 1555 1555 1.39 CISPEP 1 SER A 103 PRO A 104 0 0.19 CRYST1 111.940 111.940 137.120 90.00 90.00 120.00 P 31 2 1 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008933 0.005158 0.000000 0.00000 SCALE2 0.000000 0.010315 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007293 0.00000